Verschuren Centre
Verschuren Centre Inc. is an independent not-for-profit clean technology facility in Sydney, Nova Scotia that provides shared-access pilot-scale biomanufacturing, marine extraction, polymer processing, and net-zero modelling services to cleantech startups and SMEs across North America, funded primarily through government grants.
- Company typePrivate
- Founded2021
- HeadquartersSydney, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Verschuren Centre does
Verschuren Centre Inc. is an independent, not-for-profit clean technology development and deployment facility headquartered in Sydney, Nova Scotia, with a regional office in Halifax. Incorporated in 2021 after separating from Cape Breton University, the Centre operates seven specialized technical service teams — Bio Manufacturing, Bio Resource, Bio Agriculture, Energy Systems, Carbon Transformation, Bio Polymer, and Aquaculture — and runs a shared-asset-use infrastructure that includes Biosafety Level-1 and Level-2 labs, a 1000L pilot plant with downstream processing, a 6000L marine extraction facility, a benchtop extrusion and material processing suite, and a pilot greenhouse with controlled drip irrigation.
The Centre's core business model is a shared-asset-use / contract service model: cleantech and biotech clients — primarily startups and SMEs — pay for access to pilot-to-demonstration and full contract manufacturing capacity rather than building it themselves, with the explicit value proposition of avoiding IP dilution and major capital outlays. This is supplemented by two structural revenue streams: (i) the AscendBio acceleration program for industrial biotech and agritech companies, which bundles scientific, business, and international-network support, and (ii) the Nova Scotia Community of Interest, a collaborative ecosystem convened with Invest Nova Scotia and Michelin/Movin'On that bridges SMEs and large corporates around next-generation materials.
The organization is funded primarily through Canadian federal and provincial grants — including ACOA ($672.5K in 2021 and $2M in 2022), provincial co-investment ($2M in 2022), Canada's Ocean Supercluster and the Canadian Food Innovation Network (combined $7M in 2023), the federal government ($1M in 2023), and Next Generation Manufacturing Canada (2025). It is governed by a Board chaired (per available signals) by Dr. Beth Mason and including Annette Verschuren, with operations led by a small senior scientific and management team. The Centre has served over 50 companies across North America across sectors including functional materials, green chemicals, bioplastics, therapeutics, and aquaculture, with a particular focus on marine, forestry, and agricultural feedstocks sourced in Atlantic Canada.
Verschuren Centre firmographics
Firmographics- Name
- Verschuren Centre
- Legal name
- Verschuren Centre Inc.
- Website
- https://verschurencentre.ca
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Verschuren Centre Inc. is an independent not-for-profit clean technology facility in Sydney, Nova Scotia that provides shared-access pilot-scale biomanufacturing, marine extraction, polymer processing, and net-zero modelling services to cleantech startups and SMEs across North America, funded primarily through government grants.
- Ownership category
- akta.pro rank
Verschuren Centre industry classification
Industry- Product category
- Cleantech Biomanufacturing Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Manufacturing, MSAT & Operations Staffing (API/Biologics/Cell & Gene) (HLAGAOAL)
Keywords
Where Verschuren Centre is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Verschuren Centre business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Revenue model
- Shared-Asset-Use Facility Services: The Centre operates a shared-asset-use business model providing infrastructure access to clients without requiring them to make capital-intensive investments. Clients pay for access to pilot-to-demonstration and contract manufacturing capabilities.
- Government Support and Grants: The Centre receives support from national and provincial governments to address the capital-intensive infrastructure gap that has limited biomanufacturing deployment globally. Includes grants such as the $2M ACOA funding and provincial investments.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Verschuren Centre product offering
Product offeringCore offering
The Verschuren Centre is a clean technology development and deployment facility that provides biomanufacturing scale-up services, contract research, and shared-use pilot infrastructure to cleantech, biotech, and agritech companies. Its core offering is a portfolio of seven specialized service teams (Bio Manufacturing, Bio Resource, Bio Agriculture, Energy Systems, Carbon Transformation, Bio Polymer, and Aquaculture) supported by pilot-scale facilities, complemented by the AscendBio acceleration program and the Nova Scotia Community of Interest innovation ecosystem. Clients access pilot-to-demonstration and contract manufacturing capacity through a shared-asset-use model, avoiding capital-intensive infrastructure investments and IP dilution risk.
Product overview
The Verschuren Centre is a clean technology development and deployment facility offering a portfolio of specialized service teams and infrastructure services. The core offering consists of seven technical service teams (Bio Manufacturing, Bio Resource, Bio Agriculture, Energy Systems, Carbon Transformation, Bio Polymer, and Aquaculture) that provide client-tailored solutions. These teams are supported by a shared-use facility infrastructure including pilot-scale biomanufacturing (up to 1000L), marine extraction (up to 6000L), and controlled environment agriculture facilities. The Centre also operates the AscendBio acceleration program for biotech and agritech companies and leads the Nova Scotia Community of Interest innovation ecosystem.
Differentiator
Problem solved
Functional benefit
Brands
- AscendBio: An acceleration initiative for industrial biotech and agritech companies to scale up technologies and business operations, supported by Invest Nova Scotia's sector expertise, business support, and international networks.
- Nova Scotia Community of Interest (COI)
Products and services
- Bio Manufacturing Service Team Provides fermentation expertise and engineering know-how for process development, optimization, scale-up, and product recovery and characterization services. Enables clients to develop products from benchtop to pilot scale, validating and de-risking technology to ensure commercial targets are met.
- Bio Resource Service Team Maximizes the value of under-utilized resources (forestry, agriculture, marine, municipal waste) through greener production methods using bioprocessing and separation technologies from lab to commercial scale, enabling clean technologies that foster a circular economy.
- Bio Agriculture Service Team Provides sustainable agricultural solutions using plant growth facilities, analytical laboratories, and client-based solutions to optimize products for increased crop yield and improved agronomic characteristics.
- Energy Systems Service Team Enables the energy transition through net-zero modelling services providing technology-agnostic, system-level analysis of energy use and decarbonization options, and advances lab-proven clean thermal technologies to market, targeting industrial thermal processes.
- Carbon Transformation Service Team Provides technical expertise to develop new and improved sustainable materials for a net-zero future, transforming carbon-based feedstock into next generation materials and biofuels using state-of-the-art characterization equipment.
- Bio Polymer Service Team Develops greener packaging alternatives through upcycling, recycling, and developing new sustainable materials with benchtop extrusion and material processing capabilities, producing and testing different plastic blends and prototype properties.
- Aquaculture Service Team Develops MSX oyster disease mitigation strategies and new deployment and detection tools for Nova Scotia's Bras D'Or Lake oyster industry, with remediation strategies using organic extractives to purify contaminated water supplies.
- Shared-Use Pilot Facility Shared-asset-use infrastructure providing clients with access to Biosafety Level-1 and Level-2 labs, fully equipped analytical suite, a pilot plant facility with fermentation and downstream processing capacity up to 1000L, a marine extraction facility up to 6000L, a plant growth room, and a pilot greenhouse (30'x60' with 900 sqft automatic drip irrigation). Delivers a capital-efficient bridge toward commercialization.
- AscendBio Acceleration Program A sector acceleration program enabling companies in industrial biotech and agritech to scale up technologies and business operations, supported by Invest Nova Scotia's sector expertise, business support, and international networks. Companies receive support to achieve technical milestones, raise capital, access market insight, and connect with customers and partners.
- Nova Scotia Community of Interest (COI) A collaborative innovation ecosystem bridging SMEs and large corporate companies to accelerate adoption of next generation materials, facilitated by Movin'On (Michelin's Think & Do Tank on sustainable mobility) with the Centre as lead and Invest Nova Scotia as partner.
Quantifiable outcome
- Serving over 50 companies across North America
- +2 more outcomes
Companies that use Verschuren Centre
Customer profileNamed customers13 records
Segments4 records
Ideal customer profiles3 records
Verschuren Centre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature11 records
Verschuren Centre partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Ascend BiocorePartnership with private capital to enable companies in industrial biotech and agritech sectors to scale up technologies and business operations. The VC provides scientific and technical expertise and infrastructure while Ascend Bio provides private capital support.
- Neptune BioInnovation CentrecorePartnership creating pilot-to-demonstration and full contract manufacturing organization (CMO) capacity to serve companies across North America. Part of the end-to-end biomanufacturing scale-up infrastructure.
- Invest Nova ScotiacoreInvest Nova Scotia provides sector expertise, business support and international networks for the AscendBio program and Nova Scotia Community of Interest. Supports companies joining the VC ecosystem with acceleration initiatives.
- Movin'On (Michelin)coreThink & Do Tank on sustainable mobility powered by Michelin that facilitates the Nova Scotia Community of Interest. VC acts as lead, supported by Invest Nova Scotia and facilitated by Movin'On to bridge the gap between industry and innovation.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Verschuren Centre competitors and assessment
Company assessmentDirect peers
- Centre for Process Innovation (CPI): UK-based technology and innovation centre operating pilot-scale bioprocessing, industrial biotechnology, and sustainable manufacturing facilities. Closely comparable shared-asset-use scale-up model serving SMEs across bio-based product development, similar in mandate and infrastructure footprint to Verschuren Centre.
- Bioindustrial Innovation Canada (BIC): Sarnia, Ontario-based not-for-profit supporting commercialization of bio-based industrial technologies through pilot-scale infrastructure, funding access, and scale-up services. Directly comparable Canadian bioeconomy scale-up facility with similar SME-focused mandate and shared-use model.
- CCRM (Centre for Commercialization of Regenerative Medicine): Toronto-based Canadian organization providing process development, scale-up, and manufacturing services for cell and gene therapy companies. Comparable Canadian scale-up facility offering shared pilot infrastructure and technical expertise to SMEs in advanced biomanufacturing.
- BIOVECTRA: Canadian contract development and manufacturing organization (CDMO) serving pharma and biotech with fermentation, downstream processing, and analytical services. Directly comparable North American CDMO offering similar fermentation scale-up capabilities for biologics producers.
- Culture Biosciences: US-based contract research organization offering cloud-based fermentation and bioprocess development services. Comparable scale-up and process development provider targeting biotech startups and SMEs with similar capital-efficient outsourced model.
- Bioenterprise Canada: Canadian agri-tech accelerator providing commercialization services, mentorship, and funding connections to agritech and foodtech SMEs. Comparable Canadian SME-focused acceleration and scale-up support organization serving the bioeconomy sector.
Broad incumbents
- MaRS Discovery District: Toronto-based innovation hub offering startup support, lab infrastructure, and scale-up services across multiple sectors including cleantech and biotech. Comparable Canadian scale-up ecosystem player with broader sector mandate and significantly larger resource base.
- Ginkgo Bioworks: US-based synthetic biology platform providing cell engineering and biomanufacturing services at scale. Broader incumbent in bioengineering and biomanufacturing services with significantly larger capacity and commercial reach than Verschuren Centre's pilot scale.
- National Research Council of Canada (NRC): Canadian federal research organization operating industrial research facilities across multiple sectors including biomanufacturing. Comparable Canadian public-sector scale-up infrastructure provider, though broader in mandate and significantly larger in scale than Verschuren Centre.
Others
- ABEC: US-based manufacturer of bioreactors and fermentation equipment used in biomanufacturing. Adjacent enabling supplier to the bioprocessing infrastructure Verschuren Centre relies on; their equipment is commonly deployed in CDMO and pilot-scale facilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Verschuren Centre social profiles
Digital presenceVerschuren Centre financial estimates
Financial estimateRevenue estimate
Valuation estimate
Verschuren Centre leadership team
Management profileNumber of profiles
Profiles14 records
Verschuren Centre funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Verschuren Centre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Verschuren Centre
What does Verschuren Centre do?
The Verschuren Centre is a clean technology development and deployment facility that provides biomanufacturing scale-up services, contract research, and shared-use pilot infrastructure to cleantech, biotech, and agritech companies. Its core offering is a portfolio of seven specialized service teams (Bio Manufacturing, Bio Resource, Bio Agriculture, Energy Systems, Carbon Transformation, Bio Polymer, and Aquaculture) supported by pilot-scale facilities, complemented by the AscendBio acceleration program and the Nova Scotia Community of Interest innovation ecosystem. Clients access pilot-to-demonstration and contract manufacturing capacity through a shared-asset-use model, avoiding capital-intensive infrastructure investments and IP dilution risk.
Is Verschuren Centre a public or private company?
Verschuren Centre is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Verschuren Centre founded?
Verschuren Centre was founded in 2021. It employs 11 to 50 people.
Where is Verschuren Centre based?
Verschuren Centre is headquartered in Sydney, Canada, in the North America region.
How does Verschuren Centre make money?
Two revenue lines are on record. Shared-Asset-Use Facility Services are the primary driver. The others are government Support and Grants.
Who are Verschuren Centre's main competitors?
Direct peers on record are Centre for Process Innovation (CPI), Bioindustrial Innovation Canada (BIC), CCRM (Centre for Commercialization of Regenerative Medicine), BIOVECTRA, Culture Biosciences and Bioenterprise Canada. Broad incumbents are MaRS Discovery District, Ginkgo Bioworks and National Research Council of Canada (NRC). ABEC is listed as an others.
Does Verschuren Centre have an API?
No public API is recorded for Verschuren Centre.
What industry is Verschuren Centre in?
Verschuren Centre's product category is Cleantech Biomanufacturing Services. Its primary akta.pro industry code is HLAGAOAL, Manufacturing, MSAT & Operations Staffing (API/Biologics/Cell & Gene). Its NAICS code is 54171 and its SIC code is 8731.